Cargando…

Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides

Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnusch, Christopher J., Pieters, Roland J., Breukink, Eefjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387250/
https://www.ncbi.nlm.nih.gov/pubmed/22768121
http://dx.doi.org/10.1371/journal.pone.0039768
_version_ 1782237084641132544
author Arnusch, Christopher J.
Pieters, Roland J.
Breukink, Eefjan
author_facet Arnusch, Christopher J.
Pieters, Roland J.
Breukink, Eefjan
author_sort Arnusch, Christopher J.
collection PubMed
description Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can be modified with a high-affinity targeting module, which enables membrane permeabilization at low concentration. Magainin 2 and a truncated peptide analog were conjugated to vancomycin using click chemistry, and could be directed towards specific membrane embedded receptors both in model membrane systems and whole cells. Compared with untargeted vesicles, a gain in permeabilization efficacy of two orders of magnitude was reached with large unilamellar vesicles that included lipid II, the target of vancomycin. The truncated vancomycin-peptide conjugate showed an increased activity against vancomycin resistant Enterococci, whereas the full-length conjugate was more active against a targeted eukaryotic cell model: lipid II containing erythrocytes. This study highlights that AMPs can be made more selective and more potent against biological membranes that contain structures that can be targeted.
format Online
Article
Text
id pubmed-3387250
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33872502012-07-05 Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides Arnusch, Christopher J. Pieters, Roland J. Breukink, Eefjan PLoS One Research Article Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can be modified with a high-affinity targeting module, which enables membrane permeabilization at low concentration. Magainin 2 and a truncated peptide analog were conjugated to vancomycin using click chemistry, and could be directed towards specific membrane embedded receptors both in model membrane systems and whole cells. Compared with untargeted vesicles, a gain in permeabilization efficacy of two orders of magnitude was reached with large unilamellar vesicles that included lipid II, the target of vancomycin. The truncated vancomycin-peptide conjugate showed an increased activity against vancomycin resistant Enterococci, whereas the full-length conjugate was more active against a targeted eukaryotic cell model: lipid II containing erythrocytes. This study highlights that AMPs can be made more selective and more potent against biological membranes that contain structures that can be targeted. Public Library of Science 2012-06-29 /pmc/articles/PMC3387250/ /pubmed/22768121 http://dx.doi.org/10.1371/journal.pone.0039768 Text en Arnusch et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Arnusch, Christopher J.
Pieters, Roland J.
Breukink, Eefjan
Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
title Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
title_full Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
title_fullStr Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
title_full_unstemmed Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
title_short Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
title_sort enhanced membrane pore formation through high-affinity targeted antimicrobial peptides
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387250/
https://www.ncbi.nlm.nih.gov/pubmed/22768121
http://dx.doi.org/10.1371/journal.pone.0039768
work_keys_str_mv AT arnuschchristopherj enhancedmembraneporeformationthroughhighaffinitytargetedantimicrobialpeptides
AT pietersrolandj enhancedmembraneporeformationthroughhighaffinitytargetedantimicrobialpeptides
AT breukinkeefjan enhancedmembraneporeformationthroughhighaffinitytargetedantimicrobialpeptides